Hiroshi Watanabe
发表
T. Maruyama,
Kento Nishida,
Hiroshi Watanabe,
2021,
International journal of molecular sciences.
T. Takeo,
N. Nakagata,
T. Maruyama,
2021,
Scientific Reports.
T. Maruyama,
Hiroshi Watanabe,
Yukina Fukuchi,
2019,
Molecular pharmaceutics.
H. Maeda,
M. Otagiri,
Jun Fang,
2015,
Cancer science.
Kazuaki Matsumoto,
M. Otagiri,
T. Maruyama,
2020,
The Journal of Pharmacology and Experimental Therapeutics.
M. Otagiri,
T. Maruyama,
Kento Nishida,
2015,
Scientific Reports.
I. Narita,
T. Maruyama,
Hiroshi Watanabe,
2015,
Scientific Reports.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
1998,
Archives of Toxicology.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2013,
The Journal of Pharmacology and Experimental Therapeutics.
S. Takeoka,
M. Otagiri,
Y. Ikeda,
2015,
Journal of pharmaceutical sciences.
Panayiotis D. Megaloikonomos,
M. Harada‐Shiba,
K. Oniki,
2022,
Journal of atherosclerosis and thrombosis.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2011,
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2011,
Journal of pharmaceutical sciences.
T. Maruyama,
Hiroshi Watanabe,
H. Itoh,
2021,
Clinical and translational science.
F. Hirayama,
K. Uekama,
M. Otagiri,
2014,
Carbohydrate polymers.
T. Imai,
Hiroshi Watanabe,
T. Matsuzaki,
2007,
Drug Metabolism and Disposition.
T. Ishida,
M. Otagiri,
T. Kuroda,
2019,
FASEB bioAdvances.
H. Yamazaki,
Hidekazu Suzuki,
T. Maruyama,
2014,
Scientific Reports.
Panayiotis D. Megaloikonomos,
M. Otagiri,
J. Saruwatari,
2022,
Redox biology.
M. Suico,
T. Shuto,
H. Kai,
2020,
Antioxidants.
M. Otagiri,
T. Maruyama,
Kento Nishida,
2017,
Journal of pharmaceutical sciences.
H. Mitsuya,
C. Hirayama,
Hiroshi Watanabe,
2009,
International journal of hematology.
Hiroshi Watanabe,
A. Hamada,
H. Saito,
2003,
Journal of Pharmacology and Experimental Therapeutics.
I. Okamoto,
J. Sasaki,
M. Matsumoto,
2006,
Therapeutic drug monitoring.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2004,
Biochimica et biophysica acta.
T. Akaike,
M. Otagiri,
T. Kuroda,
2013,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
T. Maruyama,
Hiroshi Watanabe,
2018,
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
M. Otagiri,
T. Maruyama,
Kento Nishida,
2017,
Kidney international.
T. Maruyama,
Hiroshi Watanabe,
T. Mizushima,
2013,
Drug metabolism and pharmacokinetics.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2016,
Journal of Gastroenterology.
T. Maruyama,
Hiroshi Watanabe,
Y. Enoki,
2020
.
T. Maruyama,
Hiroshi Watanabe,
Y. Enoki,
2019,
Biological & pharmaceutical bulletin.
S. Tanase,
M. Otagiri,
T. Maruyama,
2004,
Pharmaceutical Research.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2016,
Journal of controlled release : official journal of the Controlled Release Society.
Tomoaki Koga,
T. Wada,
Kazuki Kobayashi,
2020,
Kidney360.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2016,
Scientific Reports.
T. Maruyama,
Hiroshi Watanabe,
M. Fukagawa,
2013,
Bone.
K. Kataoka,
M. Otagiri,
T. Maruyama,
2013,
Kidney international.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2011,
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
M. Otagiri,
Keizo Sato,
T. Maruyama,
2010,
FEBS letters.
M. Suico,
T. Shuto,
H. Kai,
2020,
Scientific Reports.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2014,
Journal of pharmaceutical sciences.
M. Otagiri,
K. Oniki,
J. Saruwatari,
2020,
Biological & pharmaceutical bulletin.
M. Otagiri,
Keizo Sato,
Yukio Fujiwara,
2015,
PloS one.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2017,
Biological & pharmaceutical bulletin.
H. Morioka,
Y. Kobashigawa,
T. Maruyama,
2020,
Journal of controlled release : official journal of the Controlled Release Society.
Hiroki Sato,
T. Maruyama,
Hiroshi Watanabe,
2010
.
Panayiotis D. Megaloikonomos,
M. Taura,
T. Shuto,
2021,
Journal of controlled release : official journal of the Controlled Release Society.
J. Sasaki,
Hiroshi Watanabe,
A. Hamada,
2008,
Biochemical pharmacology.
M. Otagiri,
T. Maruyama,
Kento Nishida,
2017,
Journal of cachexia, sarcopenia and muscle.
Panayiotis D. Megaloikonomos,
M. Nishida,
Kento Nishida,
2022,
Pharmaceutics.
T. Maruyama,
Hiroshi Watanabe,
Kai Tokumaru,
2020,
Toxins.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2015
.
K. Tomita,
K. Takeuchi,
M. Otagiri,
2011,
Journal of pharmaceutical sciences.
H. Iwata,
M. Otagiri,
K. Kaneko,
2014,
Clinical and Experimental Nephrology.
T. Ishida,
Taro Shimizu,
H. Ando,
2021,
Pharmaceutics.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2014,
Biochimica et biophysica acta.
K. Oniki,
J. Saruwatari,
Hiroshi Watanabe,
2022,
Biological & pharmaceutical bulletin.
M. Suico,
T. Shuto,
Jian-Dong Li,
2016,
Scientific Reports.
T. Maruyama,
Kento Nishida,
Hiroshi Watanabe,
2018,
Scientific Reports.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2014,
Molecular pharmaceutics.
H. Maeda,
M. Otagiri,
Hongzhuan Yin,
2014,
Journal of pharmaceutical sciences.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2012,
Drug Metabolism and Disposition.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2012
.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2011,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
H. Morioka,
T. Ishida,
M. Otagiri,
2019,
IUBMB life.
S. Takeoka,
M. Otagiri,
Y. Ikeda,
2013,
Drug Metabolism and Disposition.
Arun K. Ghosh,
H. Mitsuya,
Y. Koh,
2009,
Biological & pharmaceutical bulletin.
C. Hirayama,
Hiroshi Watanabe,
T. Kawaguchi,
2008,
Pharmaceutical Research.
H. Moriuchi,
J. Saruwatari,
Hiroshi Watanabe,
2014,
Therapeutic drug monitoring.
M. Xian,
T. Akaike,
T. Ishida,
2017,
Analytica chimica acta.
T. Abe,
T. Ishida,
M. Otagiri,
2016,
Biochemical and biophysical research communications.
S. Futaki,
T. Ishida,
Taro Shimizu,
2019,
Journal of controlled release : official journal of the Controlled Release Society.
T. Akaike,
T. Ishida,
Taro Shimizu,
2019,
Molecules.
E. Tsuchida,
M. Otagiri,
T. Maruyama,
2010,
Drug Metabolism and Disposition.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2010,
Journal of controlled release : official journal of the Controlled Release Society.
M. Hashida,
M. Otagiri,
H. Katsumi,
2010,
Journal of controlled release : official journal of the Controlled Release Society.
Kazuaki Matsumoto,
M. Otagiri,
T. Maruyama,
2010,
Drug metabolism and pharmacokinetics.
Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemia.
H. Mitsuya,
K. Sou,
M. Otagiri,
2014,
Molecular pharmaceutics.
S -nitrosated (cid:1) -1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis
Panayiotis D. Megaloikonomos,
T. Akaike,
M. Otagiri,
2012
.
Panayiotis D. Megaloikonomos,
M. Otagiri,
Hiroshi Watanabe,
2022,
International journal of biological macromolecules.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2012,
Journal of controlled release : official journal of the Controlled Release Society.
Panayiotis D. Megaloikonomos,
Hiroshi Watanabe,
Rui Fujimura,
2022,
Molecular pharmaceutics.
T. Akuta,
M. Otagiri,
T. Maruyama,
2009,
Journal of pharmaceutical sciences.
T. Maruyama,
Kento Nishida,
Hiroshi Watanabe,
2020,
Clinical biochemistry.
A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2013,
Kidney international.
H. Maeda,
M. Otagiri,
Jun Fang,
2015,
Journal of controlled release : official journal of the Controlled Release Society.
T. Ishida,
Taro Shimizu,
M. Otagiri,
2017,
Redox biology.
T. Akaike,
M. Otagiri,
T. Maruyama,
2012,
Journal of pharmaceutical sciences.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2018,
Drug delivery.
Panayiotis D. Megaloikonomos,
Kento Nishida,
Hiroshi Watanabe,
2022,
Pharmaceutics.
Panayiotis D. Megaloikonomos,
Hiroshi Watanabe,
Kai Tokumaru,
2021,
Toxins.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2013,
Drug Metabolism and Disposition.
Panayiotis D. Megaloikonomos,
M. Otagiri,
T. Maruyama,
2012
.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2015,
Biochemical pharmacology.
M. Otagiri,
J. Saruwatari,
T. Maruyama,
2020,
PloS one.
T. Maruyama,
Hiroshi Watanabe,
Kai Tokumaru,
2021,
Journal of cachexia, sarcopenia and muscle.
M. Otagiri,
Keizo Sato,
T. Maruyama,
2012,
Biochemical pharmacology.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2015,
Journal of pharmaceutical sciences.
T. Shuto,
M. Otagiri,
T. Maruyama,
2012,
Journal of pharmaceutical sciences.
T. Takeo,
N. Nakagata,
T. Maruyama,
2020,
Scientific Reports.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2021,
Biological & pharmaceutical bulletin.
Panayiotis D. Megaloikonomos,
Hiroshi Watanabe,
Y. Enoki,
2022,
Journal of cachexia, sarcopenia and muscle.
Kazuaki Matsumoto,
M. Otagiri,
T. Maruyama,
2012,
Journal of pharmaceutical sciences.
H. Horinouchi,
E. Tsuchida,
M. Otagiri,
2010,
Toxicology and applied pharmacology.
H. Horinouchi,
E. Tsuchida,
M. Otagiri,
2009,
Drug Metabolism and Disposition.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2016,
International journal of nanomedicine.
Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis.
H. Horinouchi,
M. Otagiri,
T. Maruyama,
2014,
Biomaterials.
H. Horinouchi,
M. Otagiri,
T. Maruyama,
2012
.
H. Horinouchi,
M. Otagiri,
T. Maruyama,
2011,
Journal of Pharmacology and Experimental Therapeutics.
H. Horinouchi,
M. Otagiri,
T. Maruyama,
2011,
Drug Metabolism and Disposition.
H. Horinouchi,
E. Tsuchida,
M. Otagiri,
2011,
Journal of pharmaceutical sciences.
Panayiotis D. Megaloikonomos,
H. Horinouchi,
M. Otagiri,
2010
.
H. Horinouchi,
E. Tsuchida,
M. Otagiri,
2009,
Drug Metabolism and Disposition.
Panayiotis D. Megaloikonomos,
H. Horinouchi,
E. Tsuchida,
2009
.
Sakai,
M. Otagiri,
Hiroshi Watanabe,
2009
.
T. Maruyama,
Hiroshi Watanabe,
T. Imafuku,
2019,
Biological & pharmaceutical bulletin.
N. Yamaotsu,
S. Hirono,
M. Otagiri,
2004,
Pharmaceutical Research.
Toru Maruyama,
M. Otagiri,
T. Maruyama,
2003,
Biochimica et biophysica acta.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2020,
Journal of pharmaceutical sciences.
S. Tanase,
M. Otagiri,
Hiroshi Watanabe,
2001,
Pharmaceutical Research.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2001
.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2017,
Journal of pharmaceutical sciences.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2014,
PloS one.
T. Akuta,
M. Otagiri,
T. Maruyama,
2010,
Drug Metabolism and Pharmacokinetics.
S. Curry,
Teruya Nakamura,
Y. Yamagata,
2011,
The Journal of Biological Chemistry.
S. Futaki,
H. Morioka,
M. Otagiri,
2018,
Journal of controlled release : official journal of the Controlled Release Society.
K. Tomita,
H. Nonoguchi,
Y. Kohda,
2007
.
A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells
Teruya Nakamura,
H. Arima,
M. Otagiri,
2021,
Advanced Functional Materials.
Hiroshi Watanabe,
2013,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
H. Maeda,
T. Ishida,
Taro Shimizu,
2017,
Biomaterials.
M. Otagiri,
Hiroshi Watanabe,
Y. Iwao,
2006,
Journal of molecular biology.
H. Morioka,
M. Otagiri,
T. Maruyama,
2011,
The FEBS journal.
T. Maruyama,
Hiroshi Watanabe,
2016
.
Panayiotis D. Megaloikonomos,
Hiroshi Watanabe,
Ryota Murata,
2023,
Journal of controlled release : official journal of the Controlled Release Society.
H. Shimano,
T. Matsuzaka,
Soken Tsuchiya,
2020,
Kidney360.
Norifumi Sakai,
M. Otagiri,
T. Maruyama,
2007,
Journal of pharmaceutical sciences.
Shigeyuki Esumi,
K. Tamada,
T. Takeo,
2021,
Cancer Research.
Masafumi Fukagawa,
Toru Maruyama,
Kazutaka Matsushita,
2014,
Pharmacology research & perspectives.
M. Otagiri,
T. Maruyama,
Kento Nishida,
2017,
Biochemical pharmacology.
T. Wada,
M. Otagiri,
K. Oniki,
2021,
Diabetes Care.
Panayiotis D. Megaloikonomos,
Hiroshi Watanabe,
H. Itoh,
2022,
Clinical and translational science.
Tetsuhiro Tanaka,
M. Nangaku,
R. Inagi,
2021,
Scientific Reports.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2020,
Biological & pharmaceutical bulletin.
T. Maruyama,
Hiroshi Watanabe,
Hitoshi Maeda,
2021,
Molecular pharmaceutics.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2016,
Biological & pharmaceutical bulletin.
S. Hokimoto,
E. Yamamoto,
K. Kaikita,
2015,
ESC heart failure.
S. Takeoka,
M. Otagiri,
Y. Ikeda,
2013,
Journal of pharmaceutical sciences.
S. Curry,
Teruya Nakamura,
Y. Yamagata,
2011
.
N. Yamaotsu,
S. Hirono,
M. Otagiri,
2014,
PloS one.
Panayiotis D. Megaloikonomos,
Hiroshi Watanabe,
Kai Tokumaru,
2023,
Toxins.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2014,
Front. Immunol..
T. Maruyama,
Hiroshi Watanabe,
M. Anraku,
2010
.
T. Shuto,
H. Kai,
M. Otagiri,
2012,
The Journal of Biological Chemistry.
T. Takeo,
N. Nakagata,
T. Maruyama,
2020,
Scientific Reports.
T. Maruyama,
Kento Nishida,
Hiroshi Watanabe,
2018,
Scientific Reports.
M. Otagiri,
T. Maruyama,
Kento Nishida,
2020,
Scientific Reports.
Panayiotis D. Megaloikonomos,
K. Oniki,
J. Saruwatari,
2022,
Journal of diabetes research.
S. Takeoka,
M. Otagiri,
M. Kinoshita,
2015,
Journal of pharmaceutical sciences.
K. Oniki,
K. Otake,
Y. Ogata,
2018,
CPT: pharmacometrics & systems pharmacology.
Hiroshi Watanabe,
A. Hamada,
H. Saito,
2006,
Clinical pharmacology and therapeutics.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2011,
Journal of controlled release : official journal of the Controlled Release Society.
Hiroshi Watanabe,
T. Morisaki,
T. Matsuzaki,
2007,
Pharmaceutical Research.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2017,
Biological & pharmaceutical bulletin.
T. Ishida,
M. Otagiri,
T. Ikeda,
2017,
Nitric oxide : biology and chemistry.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2021,
Toxins.
T. Takeo,
N. Nakagata,
T. Maruyama,
2021,
Molecular pharmaceutics.
Tomoaki Koga,
T. Ishida,
M. Otagiri,
2018,
Drug delivery.
M. Otagiri,
M. Kinoshita,
T. Maruyama,
2015,
The Journal of Pharmacology and Experimental Therapeutics.
Hiroshi Watanabe,
2022,
Biological & pharmaceutical bulletin.
M. Suico,
T. Shuto,
H. Kai,
2020,
Scientific Reports.
K. Sakamoto,
S. Hokimoto,
E. Yamamoto,
2015,
International journal of cardiology.
Panayiotis D. Megaloikonomos,
Teruya Nakamura,
T. Ishida,
2023,
ACS nano.
Panayiotis D. Megaloikonomos,
K. Oniki,
Y. Ogata,
2023,
Nutrients.
Panayiotis D. Megaloikonomos,
J. Saruwatari,
Kento Nishida,
2023,
Antioxidants.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2019,
Journal of pharmaceutical sciences.
T. Maruyama,
Hiroshi Watanabe,
Hitoshi Maeda,
2019,
Biological and Pharmaceutical Bulletin.
M. Otagiri,
Keizo Sato,
T. Maruyama,
2012,
Biochemical pharmacology.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2013,
Kidney international.
H. Horinouchi,
M. Otagiri,
T. Maruyama,
2011,
Journal of Pharmacology and Experimental Therapeutics.
H. Horinouchi,
E. Tsuchida,
M. Otagiri,
2010,
Toxicology and applied pharmacology.
H. Horinouchi,
E. Tsuchida,
M. Otagiri,
2009,
Drug Metabolism and Disposition.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2011,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
M. Otagiri,
T. Maruyama,
Hiroshi Watanabe,
2014,
Molecular pharmaceutics.
Panayiotis D. Megaloikonomos,
K. Azuma,
T. Higashi,
2022,
Biological & pharmaceutical bulletin.
J. Saruwatari,
Hiroshi Watanabe,
Taisei Nagasaki,
2024,
Free radical biology & medicine.
M. Xian,
T. Akaike,
T. Ishida,
2017,
Analytica chimica acta.
M. Suico,
T. Shuto,
H. Kai,
2020,
Scientific Reports.
Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemia.
H. Mitsuya,
K. Sou,
M. Otagiri,
2014,
Molecular pharmaceutics.